Sign In

Joseph Goodliffe

Scientist II, Discovery at Decibel Therapeutics

Joseph Goodliffe, PhD is a neuroscientist with experience in preclinical drug development and histology. He worked as a Scientist II in Discovery at Decibel Therapeutics from June 2019 to December 2021.4 During his time at Decibel, Goodliffe was recognized with the 2022 Decibel of the Year award for his contributions as a Senior Scientist in Histology.3

Goodliffe's research background includes work on mouse models of Down syndrome, particularly focusing on brain development, gene expression, and behavioral analysis.1 He has experience in animal models, histology, and CRO management.2

Currently, Goodliffe holds a position as a Senior Principal Scientist at Regeneron Pharmaceuticals.5 He is based in the Boston, Massachusetts area and is open to new opportunities in the biotech industry.24

Goodliffe has been involved in presenting research data supporting gene therapy approaches, indicating his continued work in the field of neuroscience and potential treatments for hearing disorders.5

Highlights

ARO's 47th Annual MidWinter Meeting in Anaheim 2024
Lifespan analysis of brain development, gene expression and ...

Related Questions

What are Joseph Goodliffe's main research interests?
What projects has Joseph Goodliffe worked on at Decibel Therapeutics?
How did Joseph Goodliffe contribute to the study on brain development and gene expression?
What is Joseph Goodliffe's educational background?
Has Joseph Goodliffe published any notable research papers?
Joseph Goodliffe
Joseph Goodliffe, photo 1
Joseph Goodliffe, photo 2
Add to my network

Location

Boston, Massachusetts, United States